Compile Data Set for Download or QSAR
Report error Found 474 Enz. Inhib. hit(s) with Target = 'Epidermal growth factor receptor [L858R]'
TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM76963(US9694011, Example 1 (Compound 17))
Affinity DataKd:  54nMT: 2°CAssay Description:Kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 ph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM76973(US9694011, Example 2 (Compound 18))
Affinity DataKd:  6.30nMT: 2°CAssay Description:Kinase-tagged T7 phage strains were prepared in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 ph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/19/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373606(US10246444, Example 33)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373698(US10246444, Example 34)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373700(US10246444, Example 36)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373701(US10246444, Example 84 isomer 2 | US10246444, Exam...)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373702(US10246444, Example 80 isomer 1)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373703(US10246444, Example 80 isomer 2)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373704(US10246444, Example 81)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373705(US10246444, Example 82)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373706(US10246444, Example 84 isomer 1)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373701(US10246444, Example 84 isomer 2 | US10246444, Exam...)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373708(US10246444, Example 85)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373709(US10246444, Example 86)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM373710(US10246444, Example 94)
Affinity DataKd:  50nMAssay Description:KINOMEscan is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50602900(CHEMBL5185704 | US11814388, Compound 3)
Affinity DataKd:  2.80E+3nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50587891(CHEMBL5181237 | US11814388, Compound 4)
Affinity DataKd:  50nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM635490(US11814388, Compound 5)
Affinity DataKd:  3.00E+4nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM635491(US11814388, Compound 6)
Affinity DataKd:  710nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM635492(US11814388, Compound 7)
Affinity DataKd:  900nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM635493(US11814388, Compound 8)
Affinity DataKd:  1.40E+4nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50602926(CHEMBL5200160 | US11814388, Compound 9 | US2025005...)
Affinity DataKd:  680nMAssay Description:Compounds 2-9 were evaluated in an ADP detection assay externally using the Kinomescan KdELECT platform from Discover X.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM50322823((S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahy...)
Affinity DataIC50: 0.0200nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
WIPO WO2022090481
PDB3D3D Structure (crystal)
TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM112499(DACOMITINIB | US8623883, No. 2 | WO2022090481, Exa...)
Affinity DataIC50: 0.0300nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
WIPO WO2022090481
PDB3D3D Structure (crystal)
TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM199995(US9670231, 1.34 | US9670231, 1.3)
Affinity DataIC50: 0.0790nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200809(US9670231, 2.6)
Affinity DataIC50: 0.0850nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM504403(US11040984, Compound 3)
Affinity DataIC50: 0.100nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM199967(BDBM200762 | US9670231, 1.1)
Affinity DataIC50: 0.110nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200501(US9670231, 1.29)
Affinity DataIC50: 0.140nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200497(US9670231, 1.25)
Affinity DataIC50: 0.150nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200810(US9670231, 2.7)
Affinity DataIC50: 0.150nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200336(US9670231, 1.12)
Affinity DataIC50: 0.160nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200793(US9670231, 1.74)
Affinity DataIC50: 0.170nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200490(US9670231, 1.22)
Affinity DataIC50: 0.230nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200491(US9670231, 1.23)
Affinity DataIC50: 0.240nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200548(US9670231, 1.51)
Affinity DataIC50: 0.240nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200478(US9670231, 1.18)
Affinity DataIC50: 0.25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM199967(BDBM200762 | US9670231, 1.1)
Affinity DataIC50: 0.25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200477(US9670231, 1.17)
Affinity DataIC50: 0.260nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200795(US9670231, 1.75)
Affinity DataIC50: 0.260nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200487(US9670231, 1.19)
Affinity DataIC50: 0.270nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200488(US9670231, 1.20)
Affinity DataIC50: 0.270nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200489(US9670231, 1.21)
Affinity DataIC50: 0.280nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200801(US9670231, 2.2)
Affinity DataIC50: 0.290nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200218(US9670231, 1.9)
Affinity DataIC50: 0.300nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM765138(US12391671, Compound 022)
Affinity DataIC50: 0.300nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200499(US9670231, 1.27)
Affinity DataIC50: 0.310nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200630(US9670231, 1.58)
Affinity DataIC50: 0.310nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200584(US9670231, 1.55)
Affinity DataIC50: 0.350nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R](Human)
Jiangsu Medolution

US Patent
LigandPNGBDBM200800(US9670231, 2.1)
Affinity DataIC50: 0.380nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Displayed 1 to 50 (of 474 total ) | Next | Last >>
Jump to: